David Olayinka Kamson, MD, PhD

Primary Academic Title

Assistant Professor of Oncology

Find a Clinical Trial

Additional Academic Titles

Assistant Professor of Neurology

Research Summary

I have a special interest in interfacing clinical outcomes and multimodality radiographic biomarkers using automated processing methods and machine learning and integrating these into the brain metastasis clinic. I am working on the development of quantitative PK/PD imaging methods and ways to translate and incorporate these into future clinical trials. It is my mission to ensure recruitment and retention of underrepresented patient populations into clinical trials.

PubMed

https://pubmed.ncbi.nlm.nih.gov/?term=Kamson+DO%5BAuthor%5D&sort

Selected Publications

• Dresser L, Yuen CA, Wilmington A, Walker M, Vogel TJ, Merrell RT, Kamson DO. Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis. Sci Rep. 2020 Oct 21;10(1):17960.

• Estephan F, Ye X, Dzaye O, Wagner-Johnston N, Swinnen L, Gladstone DE, Ambinder R, Kamson DO, Lambrecht S, Grossman SA. White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab. J Neurooncol. 2019;145(3):461– 6.

• Khalafallah AM, Jimenez AE, Romo CG, Kamson DO, Kleinberg L, Weingart J, Brem H, Grossman SA, Mukherjee D. Quantifying the utility of a multidisciplinary neuro-oncology tumor board. J Neurosurg. 2020;1(aop):1–6.

• Komáromy H, Mingchen. H, Perlaki G, Orsi G, Nagy SA, Bosnyák E, Kamson DO, John F, Trauninger A, Pfund. Z. Influence of hemispheric white matter lesions and migraine characteristics on cortical thickness and volume. J Headache Pain. 2019;20(1). 

• Ranjan S, Skorupan N, Ye X, Sivakumar A, Yankulina O, Kamson DO, Grossman SA, Dzaye O, Holdhoff M. Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncology. Neuro-Oncol Pract. 2020;7(1):52–8.